1.Novel agent for Helicobacter pylori infection management.
Ramin MOHAMMADZADEH ; Nejla AHMADIYAN
Chinese Medical Journal 2013;126(23):4535-4535
Animals
;
Anti-Bacterial Agents
;
administration & dosage
;
Escherichia coli
;
Female
;
Galactosylceramides
;
immunology
;
Gastric Mucosa
;
pathology
;
Gastritis, Atrophic
;
pathology
;
Helicobacter Infections
;
complications
;
drug therapy
;
Helicobacter pylori
;
pathogenicity
;
Humans
;
Inflammation
;
pathology
;
Intestines
;
microbiology
;
Levofloxacin
;
Lymphocyte Activation
;
Male
;
Natural Killer T-Cells
;
microbiology
;
Ofloxacin
;
administration & dosage
;
Sphingomonas
;
Stomach
;
pathology